Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methy-4-phenyl-1,2,3,6-tetrahydro pyrindine-treated C57BL/6 mice

Brain Research

Volumn 1150, Issue 1, 2007, Pages 55-61

  Bian, Gan Lan ^a   Wei, Li Chun ^b   Shi, Mei ^b   Wang, Yan Qin ^a   Cao, Rong ^a   Chen, Liang Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Basal ganglia; Fluoro Jade C; MPTP; Neurodegeneration; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DYE; FLUORO JADE C; GLIAL FIBRILLARY ACIDIC PROTEIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MESENCEPHALON; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; STAINING; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CELL COUNT; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEURONS; NEUROTOXINS; ORGANIC CHEMICALS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MUS; RODENTIA;

EID: 34247854776     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.078     Document Type: Article

References (32)

1. Ballok D.A., Millward J.M., and Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. 964 (2003) 200-210
2. Butler T.L., Kassed C.A., Sanberg P.R., Willing A.E., and Pennypacker K.R. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res. 929 (2002) 252-260
3. Cao R., Hu H.J., Wang Y.Q., Zhang J.P., and Chen L.W. Fluoro-Jade B stain method for detecting neurotoxicant kainic acid or 1-methy-4-phenyl-1,2,3,6-tetrahydro pyrindine-induced degenerative death of neurons in the basal ganglia. Acta Anat. Sin. 36 (2005) 452-455
4. Chen L.W., Wei L.C., Qiu Y., Liu H.L., Rao Z.R., Ju G., and Chan Y.S. Significant up-regulation of nestin protein in the neostriatum of MPTP-treated mice: are the striatal astrocytes regionally activated after systemic MPTP administration?. Brain Res. 925 (2002) 9-17
5. Chen L.W., Hu H.J., Liu H.L., Yung K.K.L., and Chan Y.S. Identification of BDNF in nestin-expressing astroglial cells in the neostriatum of MPTP-treated mice. Neuroscience 126 (2004) 941-953
6. Chen L.W., Zhang J.P., Shum D.K.Y., and Chan Y.S. Localization of nerve growth factor, neurotrophin-3 and glial cell line-derived neurotropic factor in nestin-expressing reactive astrocytes in the caudate-putamen of MPTP-treated C57/BL mice. J. Comp. Neurol. 497 (2006) 898-909
7. Coggeshall R.E., and Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364 (1996) 6-15
8. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 (1999) 1437-1448
9. Eyupoglu I.Y., Savaskan N.E., Brauer A.U., Nitsch R., and Heimrich B. Identification of neuronal cell death in a model of degeneration in the hippocampus. Brain Res. Protoc. 11 (2003) 1-8
10. Faherty C.J., and Smeyne R.J. Cell death in Parkinson's disease. In: Ebadi M., and Pfieffer R. (Eds). Parkinson's Disease (2004), CRC Press, Boca Raton, FL 523-535
11. Freyaldenhoven T.E., Ali S.F., and Schmued L.C. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res. 759 (1997) 9-17
12. Hamre K., Tharp R., Poon K., Xiong X., and Smeyne R.J. Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus. Brain Res. 828 (1999) 91-103
13. Hopkins K.J., Wang G., and Schmued L.C. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 864 (2000) 69-80
14. Kassed C.A., Willing A.E., Garbuzova-Davis S., Sanberg P.R., and Pennypacker K.R. Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning. Exp. Neurol. 176 (2002) 277-288
15. Myhrer T., Danscher G., and Fonnum F. Degenerative patterns following denervation of temporal structures in a rat model of mnemonic dysfunction. Brain Res. 967 (2003) 293-300
16. Narkilahti S., Pirttila T.J., Lukasiuk K., Tuunanen J., and Pitkanen A. Expression and activation of caspase 3 following status epilepticus in the rat. Eur. J. Neurosci. 18 (2003) 1486-1496
17. Nicotra A., and Parvez S.H. Cell death induced by MPTP, a substrate for monoamine oxidase B. Toxicology 153 (2000) 157-166
18. Noraberg J., Kristensen B.W., and Zimmer J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res. Protoc. 3 (1999) 278-290
19. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22 (1999) 123-144
20. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates. second ed. (2001), Academic Press, New York
21. Pitkanen A., Nissinen J., Nairismagi J., Lukasiuk K., Grohn O.H., Miettinen R., and Kauppinen R. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog. Brain Res. 135 (2002) 67-83
22. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
23. Schmued L.C., and Hopkins K.J. Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol. Pathol. 28 (2000) 91-99
24. Schmued L.C., Albertson C., and Slikker Jr. W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751 (1997) 37-46
25. Schmued L.C., Stowers C.C., Scallet A.C., and Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 1035 (2005) 24-31
26. Sedelis M., Hofele K., Auburger G.W., Morgan S., Huston J.P., and Schwarting R.K. MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav. Genet. 30 (2000) 171-182
27. Smeyne M., Goloubeva O., and Smeyne R.J. Strain-dependent susceptibility to MPTP and MPP(+)-induced parkinsonism is determined by glia. Glia 34 (2001) 73-80
28. Turmel H., Hartmann A., Parain K., Douhou A., Srinivasan A., Agid Y., and Hirsch E.C. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Mov. Disord. 16 (2001) 185-189
29. Whiteside G., Cougnon N., Hunt S.P., and Munglani R. An improved method for detection of apoptosis in tissue sections and cell culture, using the TUNEL technique combined with Hoechst stain. Brain Res. Protocol. 2 (1998) 160-164
30. Ye X., Carp R.I., Schmued L.C., and Scallet A.C. Fluoro-Jade and silver methods: application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. Brain Res. Protoc. 8 (2001) 104-112
31. Yu J., Wang J., Cadet J.L., and Angulo J.A. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain. Brain Res. 1007 (2004) 124-131
32. Zuch C.L., Nordstroem V.K., Briedrick L.A., Hoernig G.R., Granholm A.C., and Bickford P.C. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J. Comp. Neurol. 427 (2000) 440-454